русский 
Kreyòl Ayisyen
Gaeilgenah Éireann
Norsk
Srbija jezik (latinica)
bosanski
Português
Français
magyar
বাংলা
Polski
Table of contents
1. Industry background: Current status of pharmaceutical tablet coating technology development
2. Analysis of NVP coating material characteristics
3. Technological breakthroughs and application cases of NVP in pharmaceutical tablets
4. Market data and competition landscape analysis
5. Challenges and future development directions
6. Data table: Global pharmaceutical coating material performance comparison (2024-2025)
1. Industry background: Current status of pharmaceutical tablet coating technology development
Tablet coating technology is one of the core links of the pharmaceutical industry, and its core functions include:
Protect active ingredients: avoid drug degradation in gastric acid environment (such as enteric coating technology)
Improve patient compliance: improve medication experience through taste masking, moisture resistance, aesthetics and other functions
Control release rate: achieve sustained release, targeted drug delivery and other precise treatment needs
Traditional coating materials (such as hydroxypropyl methylcellulose, polyvinyl alcohol) have problems such as insufficient flexibility and complex process. In recent years, new polymer coating materials represented by N-ethylpyrrolidone (NVP) are triggering industry technological innovation with their unique physical and chemical properties.
2. Analysis of NVP coating material characteristics
Vinylpyrrolidone Homopolymer is a water-soluble polymer compound, and its coating performance advantages are reflected in:
| Features | Technical advantages | Application examples |
| High biocompatibility | Complies with USP/EP pharmaceutical excipient standards, non-cytotoxic | Oral tablets, implant device coatings |
| pH responsiveness | Quickly dissolves in the intestinal alkaline environment to achieve precise enteric release | Enteric-coated aspirin tablets |
| Film-forming flexibility | Anti-brittle cracking performance is better than traditional materials (elongation at break>200%) | Sustained-release tablets under high mechanical stress |
| Process adaptability | Supports fluidized bed coating, electrostatic spraying and other processes, reducing energy consumption by 30% | Large-scale continuous production |
3. Technological breakthroughs and application cases of NVP in pharmaceutical tablets
3.1 Innovative technological breakthroughs
Double-layer coating system:
Combined with NVP and Eudragit® L100-55 composite coating, zero gastric release + duodenum targeted release is achieved (clinical data of a certain metformin sustained-release tablets show that the blood drug concentration fluctuation coefficient is reduced from 45% to 18%).
Nanopore regulation technology:
The pore size (50-200nm) is controlled by the NVP cross-linking degree, so that the 24-hour release curve deviation of ibuprofen sustained-release tablets is <±5%.
3.2 Typical application cases
Anti-tumor drug protection:
An oral paclitaxel preparation uses Vinylpyrrolidone Linear Homopolymer / chitosan composite coating, and the drug loss rate in gastric acid environment is reduced from 32% to less than 5%.
Taste masking for children's medicine:
NVP and menthol blended coating increases the bitterness threshold of loratadine chewable tablets to 200mg/mL (only 50mg/mL in traditional process).
4. Market data and competition landscape analysis
4.1 Market size (2024-2025 forecast)
| Region | Output value in 2024 (US$ billion) | Growth rate in 2025 | Main driving factors |
| North America | 18.7 | 9.20% | Increased demand for 505(b)(2) new drug applications |
| Europe | 12.3 | 7.80% | Upgrade of generic drug consistency evaluation standards |
| Asia Pacific | 22.1 | 14.50% | China's volume-based procurement drives innovation in drug formulation processes |
4.2 Competitive enterprise landscape
First tier: BASF, Evonik (62% of NVP modified material patents)
Local enterprise: Hangzhou Rainbow Import & Export Co., Ltd (through Bomi Technology, a breakthrough in medical-grade NVP purification was achieved, with a purity of 99.99%)
5. Challenges and future development directions
5.1 Technical Challenges
Long-term stability: Crystal transformation of NVP coating under high temperature and high humidity environment (accelerated test shows a 1.8% decrease in content in 6 months)
Cost control: The price of medical-grade NVP raw materials is about 3 times that of industrial-grade (current average price $185/kg)
5.2 Innovation Directions
Intelligent responsive coating: Develop NVP-glucose oxidase composite system to achieve blood sugar concentration-dependent release of diabetic drugs
Green production process: Supercritical CO2-assisted coating technology, solvent residue can be controlled below 10ppm.
6. Data table: Global pharmaceutical coating material performance comparison (2024-2025)
| Material Type | Film forming time (min) | Enteric efficiency (%) | Friability(%) | Process temperature (℃) | Cost Index |
| NVP-Based | August 12 | ≥98 | 0.15 | 40-60 | 1.8 |
| HPMC | 15-20 | 92 | 0.35 | 70-85 | 1 |
| Polyvinyl Alcohol | October 18 | 85 | 0.28 | 65-80 | 1.2 |
| Shellac | 25-30 | 95 | 0.5 | 50-70 | 2.5 |